Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...
Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA ...
Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.
Wedbush analyst Robert Driscoll raised the firm’s price target on Kura Oncology (KURA) to $36 from $34 and keeps an Outperform rating on the ...
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the ...
Kura Oncology (KURA) stock slid 7% in post-market trading after the company issued an update on its drug ziftomenib.
Kura Oncology and Japan’s Kyowa Kirin have announced that their menin inhibitor ziftomenib met the primary endpoint in a ...
He’s been on the road since the ’90s with Chris Cornell, Don Henley, Melissa Etheridge and many others – now the session pro ...
BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib. The ...
A. Moharana et al., Chiral-induced unidirectional spin-to-charge conversion, Science Advances 11: 1, 1 January 2025, DOI: 10.1126/sciadv.ado4285 https://www.science.org/doi/10.1126/sciadv.ado4285 ...
World War II marked a significant push in military aircraft innovation, eschewing most of the biplanes from the previous war for new modern dogfighters.
The acclaimed artist and poet Gürkan Coşkun, who goes by the name Komet, has lived and worked in İstanbul and Paris since the ’70s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback